Corrigendum to “Predicting outcomes in patients with advanced non-small cell lung cancer enrolled in early phase immunotherapy trials” [Lung Cancer 120 (June) (2018) 137–141](S016950021830309X)(10.1016/j.lungcan.2018.03.020)

Hossein Maymani; Kenneth Hess; Roman Groisberg; David S. Hong; Aung Naing; Sarina Piha-Paul; Filip Janku; Siqing Fu; Apostolia M. Tsimberidou; Shubham Pant; Daniel Karp; Shuang Liu; Ming Sun; John Heymach; George Simon; Funda Meric-Bernstam; Vivek Subbiah

doi:10.1016/j.lungcan.2019.08.017

Corrigendum to “Predicting outcomes in patients with advanced non-small cell lung cancer enrolled in early phase immunotherapy trials” [Lung Cancer 120 (June) (2018) 137–141](S016950021830309X)(10.1016/j.lungcan.2018.03.020)

Hossein Maymani, Kenneth Hess, Roman Groisberg, David S. Hong, Aung Naing, Sarina Piha-Paul, Filip Janku, Siqing Fu, Apostolia M. Tsimberidou, Shubham Pant, Daniel Karp, Shuang Liu, Ming Sun, John Heymach, George Simon, Funda Meric-Bernstam, Vivek Subbiah

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The authors regret the Cancer Prevention Research Institute of Texas Grant RP110584 was incorrectly noted; it should be RP150535. This work was supported in part by Cancer Prevention Research Institute of Texas Grant RP110584 and National Center for Advancing Translational Sciences Grant UL1 TR000371 (Center for Clinical and Translational Sciences). The authors would like to apologise for any inconvenience caused.

Original language	English (US)
Pages (from-to)	158
Number of pages	1
Journal	Lung Cancer
Volume	136
DOIs	https://doi.org/10.1016/j.lungcan.2019.08.017
State	Published - Oct 2019

ASJC Scopus subject areas

Oncology
Pulmonary and Respiratory Medicine
Cancer Research

MD Anderson CCSG core facilities

Biostatistics Resource Group
Precision Oncology Decision Support

Access to Document

10.1016/j.lungcan.2019.08.017

Fingerprint

Dive into the research topics of 'Corrigendum to “Predicting outcomes in patients with advanced non-small cell lung cancer enrolled in early phase immunotherapy trials” [Lung Cancer 120 (June) (2018) 137–141](S016950021830309X)(10.1016/j.lungcan.2018.03.020)'. Together they form a unique fingerprint.

Cite this

Maymani, H., Hess, K., Groisberg, R., Hong, D. S., Naing, A., Piha-Paul, S., Janku, F., Fu, S., Tsimberidou, A. M., Pant, S., Karp, D., Liu, S., Sun, M., Heymach, J., Simon, G., Meric-Bernstam, F., & Subbiah, V. (2019). Corrigendum to “Predicting outcomes in patients with advanced non-small cell lung cancer enrolled in early phase immunotherapy trials” [Lung Cancer 120 (June) (2018) 137–141](S016950021830309X)(10.1016/j.lungcan.2018.03.020). Lung Cancer, 136, 158. https://doi.org/10.1016/j.lungcan.2019.08.017

Corrigendum to “Predicting outcomes in patients with advanced non-small cell lung cancer enrolled in early phase immunotherapy trials” [Lung Cancer 120 (June) (2018) 137–141](S016950021830309X)(10.1016/j.lungcan.2018.03.020). / Maymani, Hossein; Hess, Kenneth; Groisberg, Roman et al.
In: Lung Cancer, Vol. 136, 10.2019, p. 158.

Research output: Contribution to journal › Comment/debate › peer-review

Maymani, H, Hess, K, Groisberg, R, Hong, DS , Naing, A , Piha-Paul, S, Janku, F, Fu, S , Tsimberidou, AM , Pant, S, Karp, D, Liu, S, Sun, M, Heymach, J, Simon, G, Meric-Bernstam, F & Subbiah, V 2019, 'Corrigendum to “Predicting outcomes in patients with advanced non-small cell lung cancer enrolled in early phase immunotherapy trials” [Lung Cancer 120 (June) (2018) 137–141](S016950021830309X)(10.1016/j.lungcan.2018.03.020)', Lung Cancer, vol. 136, pp. 158. https://doi.org/10.1016/j.lungcan.2019.08.017

@article{d47edc449c4a4e1aa49b8969ef49873f,

title = "Corrigendum to “Predicting outcomes in patients with advanced non-small cell lung cancer enrolled in early phase immunotherapy trials” [Lung Cancer 120 (June) (2018) 137–141](S016950021830309X)(10.1016/j.lungcan.2018.03.020)",

abstract = "The authors regret the Cancer Prevention Research Institute of Texas Grant RP110584 was incorrectly noted; it should be RP150535. This work was supported in part by Cancer Prevention Research Institute of Texas Grant RP110584 and National Center for Advancing Translational Sciences Grant UL1 TR000371 (Center for Clinical and Translational Sciences). The authors would like to apologise for any inconvenience caused.",

author = "Hossein Maymani and Kenneth Hess and Roman Groisberg and Hong, {David S.} and Aung Naing and Sarina Piha-Paul and Filip Janku and Siqing Fu and Tsimberidou, {Apostolia M.} and Shubham Pant and Daniel Karp and Shuang Liu and Ming Sun and John Heymach and George Simon and Funda Meric-Bernstam and Vivek Subbiah",

note = "Funding Information: This work was supported in part by Cancer Prevention Research Institute of Texas Grant RP110584 and National Center for Advancing Translational Sciences Grant UL1 TR000371 (Center for Clinical and Translational Sciences). Publisher Copyright: {\textcopyright} 2019 Elsevier B.V.",

year = "2019",

month = oct,

doi = "10.1016/j.lungcan.2019.08.017",

language = "English (US)",

volume = "136",

pages = "158",

journal = "Lung Cancer",

issn = "0169-5002",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Corrigendum to “Predicting outcomes in patients with advanced non-small cell lung cancer enrolled in early phase immunotherapy trials” [Lung Cancer 120 (June) (2018) 137–141](S016950021830309X)(10.1016/j.lungcan.2018.03.020)

AU - Maymani, Hossein

AU - Hess, Kenneth

AU - Groisberg, Roman

AU - Hong, David S.

AU - Naing, Aung

AU - Piha-Paul, Sarina

AU - Janku, Filip

AU - Fu, Siqing

AU - Tsimberidou, Apostolia M.

AU - Pant, Shubham

AU - Karp, Daniel

AU - Liu, Shuang

AU - Sun, Ming

AU - Heymach, John

AU - Simon, George

AU - Meric-Bernstam, Funda

AU - Subbiah, Vivek

N1 - Funding Information: This work was supported in part by Cancer Prevention Research Institute of Texas Grant RP110584 and National Center for Advancing Translational Sciences Grant UL1 TR000371 (Center for Clinical and Translational Sciences). Publisher Copyright: © 2019 Elsevier B.V.

PY - 2019/10

Y1 - 2019/10

N2 - The authors regret the Cancer Prevention Research Institute of Texas Grant RP110584 was incorrectly noted; it should be RP150535. This work was supported in part by Cancer Prevention Research Institute of Texas Grant RP110584 and National Center for Advancing Translational Sciences Grant UL1 TR000371 (Center for Clinical and Translational Sciences). The authors would like to apologise for any inconvenience caused.

AB - The authors regret the Cancer Prevention Research Institute of Texas Grant RP110584 was incorrectly noted; it should be RP150535. This work was supported in part by Cancer Prevention Research Institute of Texas Grant RP110584 and National Center for Advancing Translational Sciences Grant UL1 TR000371 (Center for Clinical and Translational Sciences). The authors would like to apologise for any inconvenience caused.

UR - http://www.scopus.com/inward/record.url?scp=85070856309&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070856309&partnerID=8YFLogxK

U2 - 10.1016/j.lungcan.2019.08.017

DO - 10.1016/j.lungcan.2019.08.017

M3 - Comment/debate

C2 - 31445783

AN - SCOPUS:85070856309

SN - 0169-5002

VL - 136

SP - 158

JO - Lung Cancer

JF - Lung Cancer

ER -

Corrigendum to “Predicting outcomes in patients with advanced non-small cell lung cancer enrolled in early phase immunotherapy trials” [Lung Cancer 120 (June) (2018) 137–141](S016950021830309X)(10.1016/j.lungcan.2018.03.020)

Abstract

ASJC Scopus subject areas

MD Anderson CCSG core facilities

Access to Document

Other files and links

Fingerprint

Cite this